The total market for ED devices usually exhibits stable growth. However, changes in reimbursement policies have sparked fluctuations in the market.
Vancouver, BC (PRWEB) February 18, 2015
According to a new report published by i Data Research, although penis implants are a highly invasive procedure, there is an 80% to 90% satisfaction rate for men who undergo penile implant procedures seeking a more permanent solution to erectile dysfunction (ED). In 2014, the total market for erectile dysfunction treatment devices was valued at more than USD $200 million and includes inflatable, malleable and vacuum assisted erectile dysfunction devices.
“The total market for ED devices usually exhibits stable growth. However, changes in reimbursement policies have sparked fluctuations in the market,” explains Dr. Kamran Zamanian, CEO of iData. “These increases in reimbursements to ED management procedures further incentivize physicians to prescribe surgery as a treatment option.”
Other key findings from the latest edition of the iData Research report entitled U.S. Market for Urological Devices:
While drug therapy may not be suitable for some patients, such as those who take nitrates for chest pain, this treatment option is effective for 70% to 80% of patients. Therefore, as the use of drug therapy continues to be a first-line treatment for men, the total market for erectile dysfunction treatment devices will be limited.
Increased Rate of Diabetes and Neurological Diseases
Diabetes and neurological diseases are often linked to erectile dysfunction, as elevated blood glucose levels causing damage to blood vessels and nerve damage also affect blood flow to the penis. The growing prevalence of diabetes in the U.S. is expected to increase the number of erectile dysfunction patients, which will drive the overall market.
American Medical Systems’ line of penile implant devices are expected to help them maintain their leading position as they continuously develop products to meet their customer needs. Over 300,000 men have benefited from ED solutions provided by AMS.
Coloplast was another leading competitor in the erectile dysfunction treatment device market. This company’s three-piece inflatable devices have allowed them to gain market share from American Medical Systems.
For Further Information
More on the markets for erectile dysfunction devices in the U.S. can be found in this latest edition report published by iData entitled U.S. Market for Urological Devices, which covers the U.S. as a whole, as well as market segments for urinary incontinence devices, stone management devices, BPH treatment devices, urological endoscopes, prostate cancer treatment devices, urodynamic equipment, and nephrostomy devices.
The iData series on the market for urological devices also covers the U.S., India, China, Japan, and 15 countries in Europe. Full reports provide a comprehensive analysis including units sold, procedure numbers, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment.
Register online or email us at info(AT)idataresearch.net for an U.S. Market for Urological Devices report brochure and synopsis.
About Procedure Tracker
Procedure number data is available from iData’s Procedure Tracker service, which allows subscribers to define and analyze procedure data segmented by State, region, hospital, surgery centre, and physician. A customizable dashboard sorts procedure data for further analysis and research.
About iData Research
iData Research (http://www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Diabetes Drugs, Diabetes Devices, Pharmaceuticals, Anesthesiology, Wound Management, Orthopedics, Cardiovascular, Ophthalmics, Endoscopy, Gynecology, Urology and more.